Antigens, Differentiation, B-Lymphocyte
DBCAT005058Pharmacologic class
Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumors of B-cell origin. A DrugBank category of 1 drug. 1 of them is approved.
What you can answer from here — as of July 19, 2019
Which targets do Antigens, Differentiation, B-Lymphocyte share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account